Xcellerant Ventures

DeepLook Medical develops medical imaging software that uses shape-recognition to extract radiomic features from mammography images, revealing tissue morphology not visible to the unaided eye, and aims to improve early breast cancer detection, particularly in dense breast tissue, by identifying subtle data within radiological images and presenting features beyond human vision to help clinicians and reduce unnecessary procedures by lowering false positives.

CRISPRQC develops an analytics platform that enhances the efficiency and effectiveness of CRISPR gene editing. This platform is built around the CRISPR-Chip, a unique device that directly measures CRISPR activity. By simulating the gene editing process prior to cell introduction, CRISPRQC provides essential data and insights that are crucial for quality control and maximizing the potential of CRISPR technology. The platform empowers scientists to increase editing efficiency and formulate strategies for improved outcomes at the cellular level, ultimately accelerating the development of CRISPR-based products.

Lenoss Medical specializes in innovative solutions for supporting the body's natural osseous healing process. They focus on treating spinal fractures using their osteopearl VBA system, a minimally invasive and cement-free technology that harnesses healthy bone's inherent healing properties.

TruLite Health is a health equity platform focused on addressing disparities in healthcare delivery and outcomes. The company offers a comprehensive enterprise point-of-care software-as-a-service (SaaS) solution that integrates a proprietary clinical knowledge base with patient-specific clinical and social data. By doing so, TruLite Health empowers care teams to implement actionable interventions tailored to diverse populations, thus enhancing clinical, social, and behavioral support. Its innovative approach aims to close the health equity gap, ultimately contributing to improved health outcomes for patients and communities.